top of page



new panel images_speakers.jpg



Simon Tate

Managing Director

ICG Life Sciences

Simon is a successful entrepreneur and former pharmaceutical executive with over 30 years of experience in drug discovery and development. Simon joined GSK in 1989 and held several senior leadership roles during his 21-year tenure with the company. Simon is an authority in research and development associated with the pain and neuroscience therapeutic areas.
In GSK, Simon established and led the Neurosciences Discovery Technology Group, spanning Psychiatry and Neurology target validation and biomarker discovery and also established the Department of Gene Expression and Protein Biochemistry in the UK. In his role as VP and Head of Pain, Epilepsy and Migraine Drug Discovery and Development, Simon delivered successful proof of concept studies in chronic pain, high quality clinical candidates and innovative novel targets. During his time at GSK, Simon was also involved in several late-stage clinical program teams.
In 2010 Simon led the GSK spin-off of Convergence Pharmaceuticals, as Chief Scientific Officer. Simon led all Research and Development activities for Convergence, which in a short time became widely recognized as one of the leading companies in the field of pain and ion channel drug discovery and development. In 2014, Convergence reported successful clinical proof of concept studies with outstanding efficacy and safety in both trigeminal neuralgia and pain associated with sciatica. In 2015, the company was sold to Biogen for $675 million. Simon become Vice President and Head of Pain Therapeutic Area at Biogen for three years. In 2018 Simon co-founded Bridge Valley Ventures, a life sciences ventures capital company, prior to transitioning to ICG Capital in 2021.

Media Partners

Savvy Investor 2019.jpg
SPS Dutch Pension Fund & Institutional Investors’ Annual Conference
September 17, 2024
Rosarium, Amsterdam
SPS Nordic Institutional Investors’ Summit, Helsinki
September 26. 2024
Hotel Kämp, Helsinki
SPS Sustainable Investments & Current Issues Conference
October 9, 2024
Farmers and Fletchers in the City, London
SPS Local Authority Pension Funds' ESG & Current Issues Conference
October 22, 2024
The View at the Royal College of Surgeons, London
SPS Nordic Institutional Investors' Annual Conference, Stockholm
November 13, 2024
7A Strandvägen, Stockholm
SPS DC Pension Funds Update
December 3. 2024
Farmers and Fletchers in the City, London
SPS Belgian Pension Fund and Institutional Investors Summit, Belgium
January 15. 2025
SPS Alternative and Real Asset Investments Conference
February 12. 2025
SPS Local Authority Pension Funds' Annual Investment Conference
March 4. 2025
SPS Annual Nordic Investment Conference, Copenhagen
March 25. 2025
SPS Swiss Institutional Investors' Summit
April 10. 2025
SPS Nordic Sustainable Investment Conference, Stockholm
May14. 2025
SPS Irish Pension Funds' Annual Investment and Current Issues
June 11. 2025
SPS Investment Strategies for Institutional Investors Conference
June 19. 2025
SPS Fiduciary, OCIO and Investment Governance Conference
July 10. 2025
SPS Dutch Institutional Investors' Annual Conference
September 16. 2025
SPS Nordic Institutional Investors' Summit, Helsinki
September 25. 2025
SPS Local Authority Pension Funds' Topical Issues and Sustainable Investment Conference
October 22. 2025
SPS Nordic Institutional Investors' Annual Conference, Stockholm
November 5. 2025
SPS Current Investment Issues Conference
November 19. 2025
SPS DC Pension Funds Update
December 3. 2025
bottom of page